negative side effects of tirzepatide Tirzepatide and Cardiovascular Outcomes: A
Description
Semaglutide 2 4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
The GLP-1 receptor agonist albiglutide was also approved, but has been withdrawn for commercial reasons
Certain medications are known to affect hormone balance and breast tissue
Mental Health Considerations When Starting Weight Loss Therapy For people with depression or anxiety, the decision to pursue weight loss therapy involves mental health factors beyond simple calorie counting
Theyre often temporary and usually subside over time
